Stocks and Investing Stocks and Investing
Fri, October 27, 2023

Uy Ear Downgraded (ARQT) to Hold and Decreased Target to $4 on, Oct 27th, 2023


Published on 2024-10-28 07:08:50 - WOPRAI, Uy Ear
  Print publication without navigation


Uy Ear of Mizuho, Downgraded "Arcutis Biotherapeutics, Inc." (ARQT) to Hold and Decreased Target from $57 to $4 on, Oct 27th, 2023.

Uy has made no other calls on ARQT in the last 4 months.



There are 4 other peers that have a rating on ARQT. Out of the 4 peers that are also analyzing ARQT, 1 agrees with Uy's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jonathan Block of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Friday, October 13th, 2023


These are the ratings of the 3 analyists that currently disagree with Uy


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $50 on, Tuesday, August 22nd, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Thursday, August 10th, 2023
  • Ken Cacciatore of "TD Cowen" Maintained at Buy with Decreased Target to $50 on, Wednesday, August 9th, 2023
Contributing Sources